Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 5681 - 5688 of 11685 results
Arbitration Jiu Jitsu: Increasing the Pressure to Settle With a “Sealed Settlement Offer”
May 23, 2018| Blog| Viewpoint
Baiocco Confirmation Signals the Beginning of a New Paradigm at CPSC
May 23, 2018| Blog| Viewpoint
Federal Circuit clarifies that patent venue is proper only in a single judicial district within a multi-district state
May 23, 2018| Blog| Viewpoint
Ohio Submits 1115 Waiver on Work Requirements
May 23, 2018| Blog| Viewpoint
Arbitration Jujitsu: 'Sealed Settlement Offers' Add Leverage
May 22, 2018| News
DOJ Continues Aggressive Enforcement Action Against Opioid Manufacturers
May 22, 2018| Blog| Viewpoint
MintzEdge 101: The Ins and Outs of Fundraising for Startups – Blaise Barrelet (Analytics Ventures)
May 22, 2018| Podcast| Viewpoint
News & Press Releases
Mintz Expands Energy & Sustainability Practice with Projects & Infrastructure Member Luis F. Torres
January 27, 2025
Luis F. Torres has joined as a Member of Mintz’s Energy & Sustainability Practice in the firm’s Washington, DC and New York offices. An accomplished project finance lawyer, Luis’s practice focuses on the structuring, development, and financing of energy, transport, telecommunications, and other infrastructure projects in the United States, Latin America, and other jurisdictions around the globe.
Mintz represented Quorum Cyber Security, a platform company of Charlesbank Capital Partners, in its acquisition of Kivu Consulting, Inc., a global cybersecurity firm specializing in Incident Response.
Mintz Represents Granata Bio Corporation in Series A+ Funding Round
January 24, 2025
Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.